Mumbai, Nov. 21 -- Natco Pharma today announced conclusion of US FDA Inspection at its Manali, Chennai, Active Pharmaceutical Ingredients (API) Unit. The inspection was conducted from 17 - 21 November2025.

Published by HT Digital Content Services with permission from Capital Market....